[Evaluation of the effectiveness of body-psychotherapy in out-patient settings (EEBP)].

Psychother Psychosom Med Psychol

Psychotherapeutische Praxis in Zürich und Ermatingen, Schweiz.

Published: December 2006

Results from a multi-center evaluation study of body-psychotherapies are reported. The design is naturalistic and evaluates the effectiveness of routine applications of body-psychotherapy in outpatient settings. 3 German and 5 Swiss member institutes of the European Association for Body Psychotherapy (EABP: 38 members) participated, the Swiss institutes also being members of the Schweizer Charta für Psychotherapie. At three points of measurement (at intake, after 6 months and at the end of therapy [after two years at maximum]) well established questionnaires (e. g. BAI, BDI, SCL-90-R, IIP-D) were administered. Meanwhile we also have catamnestic data at 1 year after termination of therapy (n = 42). Patients who seek body-psychotherapeutic treatment (n = 342 participated in the study) compare to other outpatient psychotherapeutic patients concerning sociodemographic data, level of impairment and psychopathology. After six months of therapy (n = 253) these patients have significantly improved with small to moderate intraclass effect sizes. At the end of therapy or after two years of treatment at maximum (n = 160) large effect sizes are attained in all scales. These are lasting results according to catamnestic data (n = 42). This naturalistic prospective field study claims to supply evidence for the effectiveness of the evaluated body-psychotherapeutic methods and to classify as phase IV- ("routine application") and level I-evidence.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2006-951848DOI Listing

Publication Analysis

Top Keywords

months therapy
8
catamnestic data
8
[evaluation effectiveness
4
effectiveness body-psychotherapy
4
body-psychotherapy out-patient
4
out-patient settings
4
settings eebp]
4
eebp] multi-center
4
multi-center evaluation
4
evaluation study
4

Similar Publications

Real-time monitoring by interferometric light microscopy of phage suspensions for personalised phage therapy.

Sci Rep

December 2024

Pharmacy Department, Hospices Civils de Lyon, Hôpital E. Herriot, Plateforme FRIPHARM, 69437, Lyon, France.

Phage therapy uses viruses (phages) against antibiotic resistance. Tailoring treatments to specific patient strains requires stocks of various highly concentrated purified phages. It, therefore, faces challenges: titration duration and specificity to a phage/bacteria couple; purification affecting stability; and highly concentrated suspensions tending to aggregate.

View Article and Find Full Text PDF

Triglyceride to high density lipoprotein cholesterol ratio and major adverse cardiovascular events in ACS patients undergoing PCI.

Sci Rep

December 2024

State Key Laboratory of Frigid Zone Cardiovascular Disease, Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, 110016, China.

The triglyceride to high density lipoprotein cholesterol (TG/HDL-C) ratio has been consistently linked with the risk of coronary heart disease (CHD). Nevertheless, there is a paucity of studies focusing on acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI) or experiencing bleeding events. The study encompassed 17,643 ACS participants who underwent PCI.

View Article and Find Full Text PDF

The humeral head is the second most common anatomical site of osteonecrosis after the femoral head. Studies have reported satisfactory clinical outcomes after shoulder arthroplasty to treat osteonecrosis of the humeral head (ONHH). However, there are concerns regarding implant longevity in relatively young patients.

View Article and Find Full Text PDF

Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials.

Nat Commun

December 2024

Laboratory of Aging Research and Cancer Drug Target, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.

The immune escape capacities of XBB variants necessitate the authorization of vaccines with these antigens. In this study, we produce three recombinant trimeric proteins from the RBD sequences of Delta, BA.5, and XBB.

View Article and Find Full Text PDF

Combining genomics and epidemiology to investigate a zoonotic outbreak of rabies in Romblon Province, Philippines.

Nat Commun

December 2024

Boyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health & Veterinary Medicine, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, UK.

Rabies is a viral zoonosis that kills thousands of people annually in low- and middle-income countries across Africa and Asia where domestic dogs are the reservoir. 'Zero by 30', the global strategy to end dog-mediated human rabies, promotes a One Health approach underpinned by mass dog vaccination, post-exposure vaccination of bite victims, robust surveillance and community engagement. Using Integrated Bite Case Management (IBCM) and whole genome sequencing (WGS), we enhanced rabies surveillance to detect an outbreak in a formerly rabies-free island province in the Philippines.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!